The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReckitt Regulatory News (RKT)

Share Price Information for Reckitt (RKT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,323.00
Bid: 4,323.00
Ask: 4,324.00
Change: -56.00 (-1.28%)
Spread: 1.00 (0.023%)
Open: 4,354.00
High: 4,358.00
Low: 4,322.00
Prev. Close: 4,379.00
RKT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

13 Dec 2022 10:30

RNS Number : 5264J
Reckitt Benckiser Group PLC
13 December 2022
 

13 December 2022

 

RECKITT BENCKISER GROUP PLC

DIRECTORATE CHANGE

 

Reckitt announces the appointment of

Tamara Ingram OBE as Non-Executive Director

 

 

Reckitt Benckiser Group plc today announces the appointment of Tamara Ingram OBE to the Board as a Non-Executive Director and member of the Audit Committee, effective 1 February 2023.

 

Tamara Ingram has had an extensive career in advertising, marketing and digital communication and has a deep understanding of consumer brands and digital strategy. Tamara was the Global Chair of Wunderman Thompson until the end of 2020 and prior to that held various leadership roles at WPP plc, including Global Chief Executive Officer of J. Walter Thompson, and at WPP's wholly owned data investment division, Kantar. Prior to joining WPP plc, Tamara was Chief Executive Officer of McCann Worldgroup in London and Chief Executive Officer of Saatchi & Saatchi's London office.

 

Tamara is currently a non-executive director of Marks and Spencer Group plc and Chair of their ESG Committee. She is also a non-executive director at Intertek Group plc and a member of their Remuneration Committee, as well as a non-executive director of Marsh & McLennan Companies, Inc. and a member of their Audit and ESG Committees. Tamara was previously a non-executive director of the Sage Group plc and Serco Group plc. Tamara is also Chair of the Trustees of Asthma + Lung UK.

 

Commenting on the appointment, Chris Sinclair, Chair of the Board said:

 

"I am delighted that Tamara has agreed to join the Reckitt Board. She is an outstanding leader, with considerable expertise in global marketing services and has led renowned marketing campaigns for household brands around the world. We welcome the value she will bring to the Board."

 

The Company confirms that there is no further information to be disclosed under the requirements of Listing Rule 9.6.13R in relation to Tamara's appointment.

 

 

For further Information:

Catheryn O'Rourke

Company Secretary

Tel +44 (0) 1753 217 800

 

 

Richard Joyce

Head of Investor Relations

Tel +44 (0) 7408 812 062

 

Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108

  

About Reckitt:

 

Reckitt* exists to protect, heal and nurture in the relentless pursuit of a cleaner, healthier world. We believe that access to the highest-quality hygiene, wellness and nourishment is a right, not a privilege.

 

Reckitt is the company behind some of the world's most recognisable and trusted consumer brands in hygiene, health and nutrition, including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, Woolite and more.

 

Every day, more than 20 million Reckitt products are bought globally. We always put consumers and people first, seek out new opportunities, strive for excellence in all that we do and build shared success with all our partners. We aim to do the right thing, always.

 

We are a diverse global team of more than 43,000 colleagues. We draw on our collective energy to meet our ambitions of purpose-led brands, a healthier planet and a fairer society. Find out more, or get in touch with us at www.reckitt.com

 

*Reckitt is the trading name of the Reckitt Benckiser group of companies

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGPGBUPUPPUBW
Date   Source Headline
13th Dec 202210:30 amRNSDirectorate Change
1st Dec 202212:00 pmRNSTotal Voting Rights
7th Nov 20222:57 pmRNSDirectorate Change
1st Nov 20222:55 pmRNSTotal Voting Rights
26th Oct 20227:00 amRNS3rd Quarter Results
20th Oct 20224:46 pmRNSHolding(s) in Company
3rd Oct 20222:43 pmRNSTotal Voting Rights
29th Sep 20224:59 pmRNSDirector/PDMR Shareholding
16th Sep 20222:54 pmRNSDirector/PDMR Shareholding
7th Sep 202212:00 pmRNSDirector/PDMR Shareholding
1st Sep 202210:55 amRNSTotal Voting Rights
1st Sep 20227:00 amRNSDirectorate Change
11th Aug 202210:27 amRNSDirectorate Change
5th Aug 202212:07 pmRNSDirector Declaration
1st Aug 20224:07 pmRNSTotal Voting Rights
27th Jul 20227:00 amRNSHalf-year Results
19th Jul 20229:41 amRNSDirector Declaration
1st Jul 20221:34 pmRNSTotal Voting Rights
13th Jun 202211:45 amRNSDirector/PDMR Shareholding
1st Jun 202212:37 pmRNSTotal Voting Rights
23rd May 20225:28 pmRNSDirector/PDMR Shareholding
20th May 20225:30 pmRNSResult of AGM
3rd May 202212:54 pmRNSTotal Voting Rights
29th Apr 20227:00 amRNS1st Quarter Results
27th Apr 20224:29 pmRNSNotice of AGM
14th Apr 202212:26 pmRNSAnnual Financial Report
1st Apr 20221:57 pmRNSTotal Voting Rights
22nd Mar 202212:18 pmRNSDirector/PDMR Shareholding
1st Mar 20223:39 pmRNSTotal Voting Rights
17th Feb 20227:00 amRNSReckitt FY 2021 Results
1st Feb 202210:32 amRNSTotal Voting Rights
17th Jan 20229:00 amRNSDirectorate Change
4th Jan 202211:21 amRNSTotal Voting Rights
24th Dec 20217:00 amRNSProposed Sale of E45 to Karo Pharma
1st Dec 202111:22 amRNSTotal Voting Rights
1st Nov 202111:47 amRNSTotal Voting Rights
26th Oct 202110:01 amRNSDirectorate Change
26th Oct 20217:00 amRNS3rd Quarter Results
4th Oct 20219:35 amRNSDirectorate Change
1st Oct 202111:15 amRNSTotal Voting Rights
23rd Sep 20217:00 amRNSTrading Update & Launch of Investor Seminar Series
16th Sep 20211:20 pmRNSDirector/PDMR Shareholding
9th Sep 20219:24 amRNSClosing sale of IFCN China business to Primavera
1st Sep 202111:08 amRNSTotal Voting Rights
31st Aug 20214:00 pmRNSDirector/PDMR Shareholding
4th Aug 202110:30 amRNSDirector/PDMR Shareholding
3rd Aug 20211:30 pmRNSDirector/PDMR Shareholding
2nd Aug 202112:50 pmRNSTotal Voting Rights
30th Jul 202110:57 amRNSDirector Declaration
29th Jul 20213:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.